Friend Bookmark
Signup Sign Up | Login Login | FAQ Help
Search Your Favorites:
  • Video
  • BlogU
  • Web
  • Image
  • Music
  • Question
  • Contact us
  • Main Menu
  • Home
  • Video
  • BlogU
  • Webpage
  • Image
  • Music
  • Question
  • Contact Us
  • How to Post Video
  • How to Post Photo
  • FAQ
  • ☰
List of Popular VideosVideo List of Popular WebsitesWeb List of Popular Images and MemesImage List of Popular MusicMusic List of New ArticlesBlogU

Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

Post date: 2026-02-05 03:26:31
Views: 0
Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit declining as much as 13% this year.
Please click Here to read the full story.
 
Other Top and Latest Questions:
These names on Josh Brown's best stocks list showed strength during last week's volatility. One is forming a 'golden cross'
Housing affordability isn't just hurting buyers: More homeowners are falling behind on their mortgages
Erratic behavior in bitcoin, silver and memory stocks threatens to unnerve bull market
Why the catastrophe bond market is so hot right now
How to show question title before question meta in question list like SnowFlat theme. (Mayropro theme)
Pinterest CEO rebukes, fires 'obstructionist' employees who created tool to track layoffs
Fed's Stephen Miran resigns from White House post
Amazon makes Alexa+ AI assistant available to everyone in the U.S. nearly a year after launch
Anthropic says no to ads on Claude chatbot, weeks after OpenAI made move to test them
Trump admin to withdraw 700 federal officers from Minnesota: Homan


FAQ
Just copy & paste video embed ...
Share and bookmark ...
All interesting, funny, or ama ...
Home Home
User Profile My Profile
Post New Post

Tips
How to Post Video
How to Post Photo
Anti-Invalid Click System
How to make money from this website

There are currently 1003  visitor(s) online Now
Advertiser--> | Home | Anti-Invalid Click System |
copyright 2026 Friend Bookmark All rights reserved.